leadf
logo-loader

Proactive events

Proactive One2One Investor Forum

21 January 2021 | London

This is a virtual event

Hearing the inside story and understanding the team behind the performance is crucial to making informed decisions. Join us at our next Proactive event to see leading growth companies make their pitch

Leading companies pitching

1504530094_destiny_Pharma.png
Destiny Pharma PLC

Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets...

angle-logo.png
ANGLE PLC

ANGLE is a world leading liquid biopsy company with sample-to-answer solutions. The company's proven patent protected platforms include a circulating tumor cell (CTC) harvesting technology and a downstream analysis system for cost effective, highly...

1614865492_faron.jpg
Faron Pharmaceuticals Oy

Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. The company currently has a pipeline based on the receptors involved in regulation of immune response in oncology and...

1618219219_00agro.jpg
Argo Blockchain PLC

Argo Blockchain PLC is a publicly-traded blockchain technology company focused on large-scale cryptocurrency mining.  Headquartered in London, England, Argo is the only cryptocurrency mining company listed on the London...

Meet the real story

Join our audience of astute high net worth investors, fund managers, private client brokers and analysts

Look beyond the numbers and meet the people creating the value for shareholders

Each company has a presentation slot followed by Q & A, giving you the chance to discover the real story

Watch the event afterwards on our YouTube channel

Proactive events

The best event for investors looking for the insights that keep you a step ahead of the crowd

See more Proactive events >

One2one investor forums are suitable for sophisticated private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists. The event is not suitable for people pursuing commercial opportunities.